The University of Kansas: Journals@KU
Not a member yet
16504 research outputs found
Sort by
How is the Rate of Total Knee Arthroplasty Influenced by ACL Injury Treated by ACL Reconstruction Versus Non-Operative Treatment and How Does Prior ACL Reconstruction Compromise Outcomes: A Systematic Review
Full text linkPhytochemicals for Periprosthetic Joint Infection Prophylaxis against Staphylococcus aureus
Full text linkExploring the Role of a Lifestyle Intervention on Peri-Prostatic Adipose Tissue and Fat Metabolism in Men with Prostate Cancer
Full text linkMetabolic Dysregulation and Memory Cognition: Baseline Findings Using a Delayed Recall Test
Full text linkElevated Peripheral Blood Mononuclear Cell-derived Superoxide Production in Middle-age/Older Women with Obesity and Hypertension
Full text linkFCs and CAR Ts teamwork makes the dreamwork
Full text linkChimeric antigen receptor (CAR) T-cell therapy has recently been a huge topic in cancer immunotherapy, however the effect on solid state tumors remains limited due to poor tumor infiltration and persistence. This review is of a study by sun. et al "Dendritic cell/tumor fusion cell vaccine combined with EGFRvIII-specific nanobody CAR T cells enhances antitumor efficacy against glioblastoma."; this study uses nanobody-based CAR T cells (Nb-CAR Ts), that camelid-derived single-domain antibodies to reduce steric hindrance, which has been shown to improve tumor penetration when compared to traditional CAR receptors. They used EGFRvIII-specific Nb-CAR Ts along with a dendritic cell/tumor fusion cell (FC) to target glioblastoma. EGFRvIII Nb-CAR Ts demonstrated enhanced proliferation, activation, cytokine production, and antigen-specific cytotoxicity in vitro. Key tests showed the effectiveness of the NB CarT cell alone when compared to control groups-- both in vivo and in vitro. NB CarT cell + FC had improved outcomes, both in vivo and in vitro when compared to NB CarT cell alone, FC alone, or NB CarT cell with non fusion dendritic cell. This study shows a promsing method of treating solid state tumors.
